Despite the increase in vaccinations against COVID-19 in the United States, the director of the Centers for Disease Control and Prevention, Dr. Rochelle Valensky, warned during a press briefing Monday that she remains “deeply concerned about a potential change in the trajectory of the pandemic “.
Citing the agency’s latest figures, Valenski said the recent decline in COVID-1
“You know, the goal is not to somehow open travel, to open all, you know, things, because people – you know, we increase vaccination. The goal during these first 100 days has always been to make sure we are in a place to get out of this pandemic, “Valenski said.” In 70,000 cases a day, we are not in that place right now. So while we may have, you know, individual-level guidance, as Dr. Fauci suggested, I think we should all keep an eye on the fact that we haven’t come out of the woods yet. “
CDC SIGNS JOHNSON & JOHNSON SINGLE DOSE COVID-19 VACCINE
According to the CDC, the most recent seven-day average incidence rate – approximately 67,200 – represents an increase of just over 2% over the previous seven days. Similarly, the latest seven-day average mortality has increased by more than 2% from the previous seven days to nearly 2,000 deaths per day.
“With these new statistics, I am really concerned about reports that more and more countries are repealing the exact public health measures we have recommended to protect people from COVID-19,” she added. “I understand the temptation to do that. Seventy thousand cases a day looked good compared to where we were just a few months ago. But we can’t put up with 70,000 cases a day, 2,000 daily deaths.”
While Walensky noted that the CDC was “working actively” on guidelines on when it would be safe for Americans to resume activities such as travel, she stressed that between the current level of cases and the risk of spreading options, the United States could “completely” lose the hard-earned land we have accumulated “if opened too quickly.
“These options are a very real threat to our people and to our progress. Now is not the time to release the critical precautions we know can stop the spread of COVID-19 in our communities, not when we are so close. she said. “We have the ability to stop a potential fourth influx of cases in this country. Please remain firm in your conviction. Continue to wear a well-fitting mask and take other public health prevention actions that we know work.”
Valenski said vaccination was the key to bringing the United States out of the pandemic, and that many more Americans needed to be vaccinated to get there.
CLICK HERE TO GET FOX BUSINESS
On Sunday, Walensky signed, on the recommendation of the agency’s Advisory Committee on Immunization Practices (ACIP), that the COVID-19 vaccine from drugmaker Johnson & Johnson should be used for emergency use for people over 18 years of age.
“The Jansen vaccine is a much-needed addition to our set of tools and increases the number of available vaccine doses and enables more people to be vaccinated and protected from COVID-19,” Valenski said on Monday.
|JNJ||JOHNSON & JOHNSON||159.32||+0.86||+ 0.54%|
|PFE||PFIZER INC.||33.70||+0.18||+ 0.54%|
|MRNA||MODERN, INC.||157.40||+2.59||+ 1.67%|
The Johnson & Johnson vaccine is the third for the United States, after previous approvals for emergency use of vaccines produced by Pfizer and BioNTech and Moderna. Unlike the other two vaccines available, Johnson & Johnson’s requires a single dose and does not need to be kept in a freezer.
According to an FDA analysis, the Johnson & Johnson vaccine was approximately 67% effective in preventing moderate to severe cases within 14 days after dosing and 66% effective against severe to critical cases after 28 days. In addition, the vaccine was approximately 77% effective in preventing severe or critical COVID-19 occurring at least 14 days after vaccination, and 85% effective in preventing severe or critical COVID-19 occurring at least 28 days after vaccination. vaccination.
Meanwhile, Pfizer and Moderna vaccines were 95% and 94.1% effective, respectively.
The ACIP does not indicate a preference for a specific vaccine against COVID-19. Instead, the group of independent health experts encourages people to get one of the available vaccines as early as possible.
CLICK HERE TO READ MORE ABOUT FOX BUSINESS
According to the latest CDC data, more than 76 million COVID-19 vaccines have been given in the United States, with nearly 50 million Americans receiving at least one dose of COVID-19 vaccine.
Deliveries of Johnson and Johnson’s initial deliveries of 3.9 million doses of vaccines to state health departments, pharmacies, federally qualified health centers and municipal vaccination centers across the country are expected as early as Tuesday.
Johnson & Johnson CEO Paul Stofels told FOX Business on Monday that the company expects to deliver enough single-dose vaccines by the end of March to vaccinate more than 20 million Americans and 100 million by the end of June. The company is also set to produce 1 billion doses for global distribution by the end of 2021.